Research Directory

Antimicrobial resistance: finding solutions

Read more

An analysis of 2010 oncology drug failures

Read more

Shortage of risk capital keeps befuddling markets

Read more

Finding solutions to drug resistance

Read more

Immunocore pioneers new safety studies

Read more

Developing biosimilar monoclonal antibodies will not be easy

Read more

Gene therapy: a history and appraisal

Read more

Oxford BioMedica perfects lentiviral vectors for gene therapy

Read more

Symphogen sees opportunities in antibody mixtures

Read more

Capital efficiency -- a new norm

Read more